EUVIMEDEUVIMED entdecken
Crossref

The pTau217/Aβ1-42 plasma ratio: The first FDA-cleared blood biomarker test for diagnosis of Alzheimer's disease

Shasha Hu, Haizhou Yu, Jianjun Gao

Drug Discoveries & Therapeutics · 30.06.2025 · 19 (3) · 208-209

DOI: 10.5582/ddt.2025.01055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Discoveries & Therapeutics, erschienen am 30.06.2025. Verfasst von Shasha Hu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Peptide Fragments, tau Proteins. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloid beta-PeptidesPeptide Fragmentstau ProteinsHumansBiomarkersPositron-Emission TomographyUnited StatesUnited States Food and Drug Administration

Stichwörter der Autor:innen

Alzheimer's diseaseAβ42/40Lumipulse GPrecivityAD2β Amyloid 1-42

Substanzen

Amyloid beta-Peptidesamyloid beta-protein (1-42)BiomarkersMAPT protein, humanPeptide Fragmentstau Proteins

Autor:innen und Institutionen

  • Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • Department of Anesthesiology, Weihai Central Hospital Affiliated to Qingdao University, Weihai, Shandong, China.
  • Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, Shandong, China.

Zitieren

APA

Hu, S., Yu, H., & Gao, J. (2025). The pTau217/Aβ1-42 plasma ratio: The first FDA-cleared blood biomarker test for diagnosis of Alzheimer's disease. Drug Discoveries & Therapeutics, 19(3), 208-209. https://doi.org/10.5582/ddt.2025.01055

Vancouver

Hu S, Yu H, Gao J. The pTau217/Aβ1-42 plasma ratio: The first FDA-cleared blood biomarker test for diagnosis of Alzheimer's disease. Drug Discoveries & Therapeutics. 2025;19(3):208-209. doi:10.5582/ddt.2025.01055

BibTeX
@article{Hu2025,
  author = {Hu, Shasha and Yu, Haizhou and Gao, Jianjun},
  title = {The pTau217/Aβ1-42 plasma ratio: The first FDA-cleared blood biomarker test for diagnosis of Alzheimer's disease},
  journal = {Drug Discoveries & Therapeutics},
  year = {2025},
  volume = {19},
  number = {3},
  pages = {208--209},
  doi = {10.5582/ddt.2025.01055}
}
Kostenlos starten →